| # | Name | Description | Category | Type | Source | Website |
|---|
| # | Opportunity | Type | Region / Country | Amount | Deadline | Source |
|---|---|---|---|---|---|---|
| 39251 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tiotropiumbromid ausschließlich in der Dafo Lösung zur Inhalation, ATC R03BB04 f. d. Z. 01.11.25 - 31.10.27 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Sep 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 |
||||||
| 39252 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Allergenextrakt aus Birkenpollen ausschießlich Dafo SUT, ATC V01AA05 für die Zeit 01.11.2025 - 31.10.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Sep 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 |
||||||
| 39253 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Raltegravir, ATC J05AJ01 für die Zeit 01.11.2025 - 31.10.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Sep 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 |
||||||
| 39254 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Glycopyrroniumbromid, ATC R03BB06 für die Zeit 01.11.2025 - 31.10.2026 (zzgl. Verlängerungsoption 1x12 Mon) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Sep 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 |
||||||
| 39255 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Filgotinib, ATC L04AF04 für die Zeit 01.11.2025 - 31.10.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Sep 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 |
||||||
| 39256 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Formoterol, Beclometason, Glycopyrronium, f. d. Z. 01.11.25 - 31.10.26 (zzgl. Verlängerungsoption 1x12 Mon) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Sep 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 |
||||||
| 39257 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Lenograstim, ATC L03AA10 für die Zeit 01.11.2025 - 31.10.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Sep 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 |
||||||
| 39258 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Follitropin beta, ATC G03GA06 für die Zeit 01.11.2025 - 31.10.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Sep 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 |
||||||
| 39259 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Natriumphenylbutyrat, ATC A16AX03 für die Zeit 01.11.2025 - 31.10.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Sep 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 |
||||||
| 39260 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clobetasol ausschließlich in der Darreichungsform Schaum, ATC D07AD01 für die Zeit 01.11.2025 - 31.10.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Sep 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 |
||||||
| 39261 | Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-09 Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Sep 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 |
||||||
| 39262 | Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-09 Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Sep 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 |
||||||
| 39263 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Sep 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 |
||||||
| 39264 | Lithuania – Crossheads – 31616 Geležinkelio iešmai Buyer: LTG Kompetencijų centras UAB (PV) | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-... | Tender Procurement Contract | Lithuania | Not provided on the source page. Please check the official source. | Open Sep 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: LTG Kompetencijų centras UAB (PV) | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-09-05 |
||||||
| 39265 | Lithuania – Translation services – Vertimo paslaugų užsakymai per CPO LT elektroninį katalogą Buyer: Viešoji įstaiga CPO LT | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-09-06 | Tender Procurement Contract | Lithuania | Not provided on the source page. Please check the official source. | Open Sep 6, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Viešoji įstaiga CPO LT | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-09-06 |
||||||
| 39266 | NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public heal... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2027 Open | Grants.gov |
|
Source description
The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers. |
||||||
| 39267 | Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial inv... | Grant Mixed | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2027 Open | Grants.gov |
|
Source description
This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising bioengineering tools and technologies that can address important biomedical problems. The objectives are to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need and are capable of enhancing our understanding of life science processes or the practice of medicine. Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies. The goal of the program is to support technological innovations that deliver new capabilities which can realize meaningful solutions within 5 10 years. |
||||||
| 39268 | Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed) The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualiz... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2027 Open | Grants.gov |
|
Source description
The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualization of qualities of the environment that can support language development in children and that focuses on the development of novel measures of childrens language development. The overall goal is to build the number of strengths-focused, culturally and linguistically responsive, and generalizable toolsto further our understanding of childrens language development and/or impairment, and predictors thereof. |
||||||
| 39269 | Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed) The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in comp... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2027 Open | Grants.gov |
|
Source description
The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease. This FOA supports fundamental genomics research developing innovative analytical methodologies and approaches, early-stage development of tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems. All applications should address how the methods would scale to address increasingly larger data sets. |
||||||
| 39270 | Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in comp... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2027 Open | Grants.gov |
|
Source description
The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease. This FOA supports fundamental genomics research developing innovative analytical methodologies and approaches, early-stage development of tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems. All applications should address how the methods would scale to address increasingly larger data sets. |
||||||
| 39271 | Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed) The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualiz... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2027 Open | Grants.gov |
|
Source description
The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualization of qualities of the environment that can support language development in children and that focuses on the development of novel measures of childrens language development. The overall goal is to build the number of strengths-focused, culturally and linguistically responsive, and generalizable toolsto further our understanding of childrens language development and/or impairment, and predictors thereof. |
||||||
| 39272 | D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional) Data science is an important cross-cutting research approach in the 2022 - 2026 NIDA Strategic Plan and increasing the capacity of... | Grant Cash Grant | United States | Award ceiling: $100,000 | Open Sep 7, 2027 Open | Grants.gov |
|
Source description
Data science is an important cross-cutting research approach in the 2022 - 2026 NIDA Strategic Plan and increasing the capacity of experts in addiction related data science is critical. The purpose of this Notice is to facilitate the entry of investigators to the area of addiction-related data science, including newly independent data scientists or established investigators seeking to incorporate novel and cutting-edge data science methodologies into their research programs for the first time. Through this opportunity, investigators will propose to apply emerging data science methods to answer critical questions requiring advanced data analytic strategies. Projects should be small in scale and answer specific research questions or provide preliminary data for a larger scale project. Applicants are encouraged to use existing datasets, follow FAIR principles, and, when applicable, attend to ethical concerns in the conduct of research involving human subjects. Ultimately, the aim is to expedite the development of robust research programs focused on the convergence of innovative data science techniques and addiction research, with initial projects serving as precursors for subsequent, more expansive research projects. |
||||||
| 39273 | Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) This PAR is being reissued in accordance with the simplified review criteria in effect for application due dates after January 25,... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2027 Open | Grants.gov |
|
Source description
This PAR is being reissued in accordance with the simplified review criteria in effect for application due dates after January 25, 2025. The objective of this funding opportunity is to support non-pharmacological interventions to promote sleep health, reduce sleep health disparities, and examine sleep as a modifiable factor to reduce health disparities for other health outcomes among populations that experience health disparities. |
||||||
| 39274 | Ireland – Education and training services – Invitation to join a Panel of Tutors for recreational and educational support on a part-time basis at Oberstown. Buyer: Oberstown Children Detention Campus | Notice type: cn-social | Procedure: open | Contract: services | Deadline: 2027-09-09 | Tender Procurement Contract | Ireland | Not provided on the source page. Please check the official source. | Open Sep 9, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Oberstown Children Detention Campus | Notice type: cn-social | Procedure: open | Contract: services | Deadline: 2027-09-09 |
||||||
| 39275 | Bulgaria – Pharmaceutical products – Динамична система за покупки на лекарствени продукти за нуждите на лечебното заведение Buyer: МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ СВ. ИВАН РИЛСКИ ГОРНА ОРЯХОВИЦА ЕООД | Notice type: cn-standard | Procedure: restr... | Tender Procurement Contract | Bulgaria | Not provided on the source page. Please check the official source. | Open Sep 10, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ СВ. ИВАН РИЛСКИ ГОРНА ОРЯХОВИЦА ЕООД | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-09-10 |
||||||